Renal Insufficiency: all 2,030 studies

Page 3 of 21. Open to participants first (168), then studies with results posted, then the rest; newest registration first within each.

• Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous FistulasTerminatedNCT04376567Not applicableResults posted
• Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)CompletedNCT04281784Not applicableResults posted
• Renal Impairment Study of PF-06700841CompletedNCT04260464Phase 1Results posted
• Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney FunctionTerminatedNCT04258423Phase 3Results posted
• BEACH Trial: Bovine Early Access, Compatibility and Hemostasis TrialTerminatedNCT04146012Phase 3Results posted
• Improving Patient Prioritization During Hospital-homecare TransitionCompletedNCT04136951Not applicableResults posted
• Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney FunctionCompletedNCT04119843Phase 3Results posted
• Everolimus Monotherapy as Immunosuppression After Liver TransplantTerminatedNCT04063865Phase 3Results posted
• A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy KidneysCompletedNCT04056455Phase 1Results posted
• A Renal Impairment Study for PF-06651600TerminatedNCT04037865Phase 1Results posted
• A Brief Mindful Drinking/Eating Intervention for Hemodialysis Patients With Fluid RestrictionsCompletedNCT04016311Not applicableResults posted
• Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD TrialCompletedNCT03923933Phase 2Results posted
• Neuromuscular Blockade in Patients With Severe Renal ImpairmentCompletedNCT03904550Phase 2Results posted
• Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal FunctionCompletedNCT03896750Phase 1Results posted
• Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)CompletedNCT03873038Phase 1Results posted
• XIENCE 28 USA StudyCompletedNCT03815175Not applicableResults posted
• A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver ProblemsCompletedNCT03814005Phase 1Results posted
• Multi-center Study to Transplant Hepatitis-C Infected KidneysCompletedNCT03781726Phase 4Results posted
• A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02CompletedNCT03776539Phase 1Results posted
• Facilitating Communication StudyCompletedNCT03721952Not applicableResults posted
• A Renal Impairment Study for PF-04965842CompletedNCT03660241Phase 1Results posted
• Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney FailureTerminatedNCT03645681Not applicableResults posted
• PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal FunctionTerminatedNCT03639610Phase 2Results posted
• Deprescribing for Older Dialysis PatientsCompletedNCT03631290Results posted
• Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.CompletedNCT03552393Phase 2Results posted
• A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well ToleratedCompletedNCT03550378Phase 2Results posted
• Lorlatinib Renal Impairment StudyCompletedNCT03542305Phase 1Results posted
• Clinical Study to Assess the Performance of the Dialyzer With Endexo™CompletedNCT03536663Not applicableResults posted
• Incidence of HANA Conditions in HIV-infected IndividualsCompletedNCT03483584Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney FunctionCompletedNCT03482024Phase 1Results posted
• Sodium Chloride and Contrast NephropathyCompletedNCT03476460Phase 2Results posted
• Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal ImpairmentCompletedNCT03443063Phase 1Results posted
• Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal FunctionCompletedNCT03442725Phase 1Results posted
• XIENCE 28 Global StudyCompletedNCT03355742Not applicableResults posted
• Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal FunctionCompletedNCT03318809Phase 1Results posted
• Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)CompletedNCT03311841Phase 1Results posted
• A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the BodyCompletedNCT03302091Phase 1Results posted
• A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954CompletedNCT03296787Phase 1Results posted
• Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal ImpairmentCompletedNCT03289208Phase 1Results posted
• Omega 3 Fatty Acids in Patients With Chronic Renal DiseaseCompletedNCT03280615Phase 3Results posted
• Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)CompletedNCT03259087Phase 1Results posted
• VasQ External Support for Arteriovenous FistulaCompletedNCT03242343Not applicableResults posted
• Study of Copanlisib in Hepatic or Renal ImpairmentCompletedNCT03172884Phase 1Results posted
• Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)CompletedNCT03171545Not applicableResults posted
• The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.TerminatedNCT03152084Phase 4Results posted
• Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.CompletedNCT03131479Phase 2Results posted
• The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)CompletedNCT03108924Phase 1Results posted
• Study of Oral Lasmiditan in Participants With Normal and Impaired Renal FunctionCompletedNCT03009162Phase 1Results posted
• Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney DiseaseCompletedNCT02968368Phase 3Results posted
• Pharmacokinetics of Lanraplenib in Adults With Impaired Renal FunctionCompletedNCT02959138Phase 1Results posted
• Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney TransplantCompletedNCT02945150Phase 4Results posted
• Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)CompletedNCT02933450Phase 4Results posted
• HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal TransplantCompletedNCT02902120Phase 4Results posted
• Chlorthalidone in Chronic Kidney DiseaseCompletedNCT02841280Phase 2Results posted
• Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis CentersCompletedNCT02823600Not applicableResults posted
• Catheter System Feasibility Clinical TrialCompletedNCT02816398Not applicableResults posted
• Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal InsufficiencyTerminatedNCT02808052Phase 1Results posted
• Targeting Central Pulsatile Hemodynamics in Chronic Kidney DiseaseTerminatedNCT02791906Phase 2Results posted
• A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch TestCompletedNCT02790437Phase 2Results posted
• Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color TypesCompletedNCT02772276Phase 2Results posted
• A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial InfarctionCompletedNCT02742103Phase 2Results posted
• Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCompletedNCT02729038Phase 1Results posted
• VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDCCompletedNCT02685995Not applicableResults posted
• Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal FunctionCompletedNCT02678000Phase 2Results posted
• Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030)CompletedNCT02661126Phase 1Results posted
• Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream InfectionCompletedNCT02651428Phase 3Results posted
• Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney DiseaseCompletedNCT02648347Phase 3Results posted
• Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisCompletedNCT02644941Phase 3Results posted
• A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051)CompletedNCT02641067Phase 1Results posted
• Advance Care Planning With Older Patients Who Have End-stage Kidney DiseaseCompletedNCT02631200Not applicableResults posted
• Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm InfantsTerminatedNCT02620761Phase 2/3Results posted
• DS-5565 Phase III Study for Renal Impairment in Japanese SubjectsCompletedNCT02607280Phase 3Results posted
• Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal DialysisCompletedNCT02596945Results posted
• Diuretic/Cool Dialysate TrialTerminatedNCT02593526Not applicableResults posted
• The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal DysfunctionCompletedNCT02554253Phase 2Results posted
• Linagliptin's Effect on CD34+ Stem CellsCompletedNCT02467478Phase 4Results posted
• Renal Osteodystrophy: An Individual Management ApproachCompletedNCT02440581Not applicableResults posted
• Optimising Renal Outcome in Myeloma Renal FailureCompletedNCT02424851Phase 2Results posted
• Does Intravenous Iron Therapy Decrease Serum Phosphorous Levels?CompletedNCT02420119Results posted
• Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)CompletedNCT02405195Results posted
• Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal ImpairmentCompletedNCT02402452Phase 1Results posted
• Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal FunctionCompletedNCT02400307Phase 1Results posted
• Evaluation of Gadoterate in Patients With Renal DysfunctionTerminatedNCT02382380Phase 4Results posted
• Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic ImpairmentCompletedNCT02367872Phase 1Results posted
• GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell TransplantTerminatedNCT02360111Not applicableResults posted
• Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)CompletedNCT02341599Phase 1Results posted
• Pharmacokinetic Comparison Of All FK-506 FormulationsCompletedNCT02339246Phase 3Results posted
• A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationCompletedNCT02331680Phase 2Results posted
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)CompletedNCT02314403Phase 1Results posted
• Clinical Study of Asahi ViE Dialyzer in CanadaCompletedNCT02292212Not applicableResults posted
• Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of EvolocumabCompletedNCT02275156Phase 1Results posted
• Mild, Moderate and Severe Renal Impairment StudyCompletedNCT02219516Phase 1Results posted
• Belatacept 3 Month Post Transplant Conversion StudyCompletedNCT02213068Phase 4Results posted
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney DiseaseCompletedNCT02207088Phase 3Results posted
• A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With HemodialysisCompletedNCT02144285Phase 1Results posted
• C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRICompletedNCT02134314Phase 1/2Results posted
• Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentCompletedNCT02128490Phase 2Results posted
• Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)TerminatedNCT02116660Phase 2Results posted
• Artegraft Versus Propaten Dialysis GraftsTerminatedNCT02099344Phase 4Results posted
• Afatinib in Subjects With Kidney DysfunctionCompletedNCT02096718Phase 1Results posted

← Renal Insufficiency overview